Cargando…

Neoadjuvant and adjuvant therapy in esophageal cancer

Esophageal cancer is an aggressive malignancy that carries a high mortality rate. The treatment of locally advanced resectable esophageal cancer requires a multimodal approach involving chemotherapy, radiation therapy, and surgical resection. Optimal treatment combinations and sequences for squamous...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weiss, Jennifer A., Jain, Shikha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Review Article on Current Management of Upper Gastrointestinal Malignancies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502534/ https://www.ncbi.nlm.nih.gov/pubmed/37720447 http://dx.doi.org/10.21037/jgo-22-735

Ejemplares similares

Robotic surgery for esophageal cancer: what is the evidence?
por: Schlottmann, Francisco, et al.
Publicado: (2022)

Controversies in the surgical management of esophageal adenocarcinoma
por: Worrell, Stephanie G., et al.
Publicado: (2023)

Antireflux surgery to prevent the progression from Barrett’s esophagus to esophageal adenocarcinoma: yes or no?
por: Patti, Marco G., et al.
Publicado: (2022)

A more radical perspective on surgical approach and outcomes in pancreatic cancer—a narrative review
por: Fernandes, Eduardo de Souza M., et al.
Publicado: (2023)

Surgical approach to achieve R0 resections in primary and metastatic liver tumors: a literature review
por: Vargas, Paola A., et al.
Publicado: (2023)

Impact of neoadjuvant therapy followed by laparoscopic radical gastrectomy with D2 lymph node dissection in Western population: A multi‐institutional propensity score‐matched study
por: Bracale, Umberto, et al.
Publicado: (2021)

Current management of gastric adenocarcinoma: a narrative review
por: Nevo, Yehonatan, et al.
Publicado: (2023)

Detection of sarcopenic obesity and prediction of long‐term survival in patients with gastric cancer using preoperative computed tomography and machine learning
por: Kim, Jaehyuk, et al.
Publicado: (2021)

Gastric schwannoma: a benign tumour often mistaken clinically, radiologically and histopathologically for a gastrointestinal stromal tumour – a case series
por: Williamson, JML, et al.
Publicado: (2012)

Addition of HER2 and CD44 to (18)F-FDG PET–based clinico-radiomic models enhances prediction of neoadjuvant chemoradiotherapy response in esophageal cancer
por: Beukinga, Roelof J., et al.
Publicado: (2020)

Early Gastric Cancer Associated With Gastric Sarcoidosis
por: Matsubara, Takeshi, et al.
Publicado: (2015)

Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs
por: Hao, Zhonglin, et al.
Publicado: (2022)

Toripalimab Plus Paclitaxel and Carboplatin as Neoadjuvant Therapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
por: He, Wenwu, et al.
Publicado: (2022)

Effect of Extending the Original Eligibility Criteria for the CROSS Neoadjuvant Chemoradiotherapy on Toxicity and Survival in Esophageal Cancer
por: de Heer, E. C., et al.
Publicado: (2017)

A Highly Active and Tolerable Neoadjuvant Regimen Combining Paclitaxel, Carboplatin, 5-FU, and Radiation Therapy in Patients with Stage II and III Esophageal Cancer
por: van de Schoot, L., et al.
Publicado: (2007)

Potential Predictive Immune and Metabolic Biomarkers of Tumor Microenvironment Regarding Pathological and Clinical Response in Esophageal Cancer After Neoadjuvant Chemoradiotherapy: A Systematic Review
por: Wang, H. H., et al.
Publicado: (2023)

Better Survival in Patients with Esophageal Cancer After Surgical Treatment in University Hospitals: A Plea for Performance by Surgical Oncologists
por: Verhoef, Christian, et al.
Publicado: (2007)

Boerhaave syndrome in an elderly man successfully treated with 3-month indwelling esophageal stent
por: Y, Kopelman, et al.
Publicado: (2018)

Histological Regression of Squamous Esophageal Carcinoma Assessed by Percentage of Residual Viable Cells after Neoadjuvant Chemoradiation is an Important Prognostic Factor
por: Tong, Daniel King Hung, et al.
Publicado: (2010)

Metabolic tumour and nodal response to neoadjuvant chemotherapy on FDG PET-CT as a predictor of pathological response and survival in patients with oesophageal adenocarcinoma
por: Moore, Jonathan L., et al.
Publicado: (2023)

Outcome of Patients Treated Within and Outside a Randomized Clinical Trial on Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: Extrapolation of a Randomized Clinical Trial (CROSS)
por: Toxopeus, Eelke, et al.
Publicado: (2018)

Phase 1 Study of Neoadjuvant Short-Course Radiation Therapy Concurrent With Infusional 5-Fluorouracil for the Treatment of Locally Advanced Rectal Cancer
por: Fields, Emma C., et al.
Publicado: (2019)

Lymph node metastasis can be determined by just tumor depth and lymphovascular invasion in early gastric cancer patients after endoscopic submucosal dissection
por: Goto, Atsushi, et al.
Publicado: (2017)

Adjuvant Therapy for Esophageal Squamous Cell Carcinoma
por: Sun, Jong-Mu
Publicado: (2020)

The presence of an asymptomatic aberrant right subclavian artery: A potential risk factor in esophageal surgery?
por: Chon, Seung-Hun, et al.
Publicado: (2017)

Massive upper gastrointestinal bleeding caused by an intercostal arterio-esophageal fistula: A rare case report
por: Yang, Kai-Chun, et al.
Publicado: (2020)

Omental herniation through the esophageal hiatus: A rare cause of gastric outlet obstruction and its CT findings
por: Tanaka, Yoshikazu, et al.
Publicado: (2020)

A Comparison of Grade 4 Lymphopenia With Proton Versus Photon Radiation Therapy for Esophageal Cancer
por: Routman, David M., et al.
Publicado: (2019)

Effects of focused continuous pulsed electromagnetic field therapy on early tendon-to-bone healing: rat supraspinatus detachment and repair model
por: Dolkart, Oleg, et al.
Publicado: (2021)

Cardiopulmonary exercise testing as a predictor of complications in oesophagogastric cancer surgery
por: Moyes, LH, et al.
Publicado: (2013)

Systemic inflammation score is a prognostic marker after curative resection in gastric cancer
por: Ma, Mingzhe, et al.
Publicado: (2019)

Surgery for Esophageal Cancer: Quality of Life Matters
por: Salo, Jonathan C
Publicado: (2009)

Targeted Therapy in Biliary Tract Cancers
por: Merla, Amartej, et al.
Publicado: (2015)

Systemic Therapy for Metastatic Pancreatic Cancer
por: Ettrich, Thomas J., et al.
Publicado: (2021)

Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma
por: Goense, Lucas, et al.
Publicado: (2018)

Treatment Switch in Poor Responders with Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy
por: Liu, Zining, et al.
Publicado: (2021)

Initial Results of a Prospective Study of Adjuvant Pancreatic Stereotactic Body Radiation Therapy for Close or Positive Margins
por: Bernard, Mark E., et al.
Publicado: (2018)

Endoscopic Management of Tumor Bleeding from Inoperable Gastric Cancer
por: Kim, Young-Il, et al.
Publicado: (2015)

The Current Evidence on Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma
por: Oh, Dongryul, et al.
Publicado: (2020)

Survival Outcomes of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer
por: Khalil, Lana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dhaa73ngqs87g5ikl960fmjdkq